Roflumilast: the fourth Mousquetaire in COPD pharmacological treatment
Submitted: August 18, 2015
Accepted: August 18, 2015
Published: August 19, 2015
Accepted: August 18, 2015
Abstract Views: 896
PDF: 585
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Carlo Lombardi, Marco Sbolli, Dario Cani, Garbriele Masini, Marco Metra, Pompilio Faggiano, Preoperative cardiac risks in noncardiac surgery: The role of coronary angiography , Monaldi Archives for Chest Disease: Vol. 87 No. 2 (2017)
- Elena Zelikovna Golukhova, Inessa Viktorovna Slivneva, Andrey Lvovich Pylev, Olga Sergeevna Kozlova, Karen Valerievich Petrosyan, Denis Sergeevich Romanov, Alexander Yurievich Volkov, Optimal treatment strategies for coronary heart disease in cancer patients: a complex clinical case , Monaldi Archives for Chest Disease: Early Access
- Amit Sharma, Deepak Rathi, Prerna Jain, Devika Tayal, Hematological and clinical profiling of chronic obstructive pulmonary disease: a comprehensive study , Monaldi Archives for Chest Disease: Early Access
- Mamta Singh, Kunal Deokar, Bibhuti Prassan Sinha, Monika Keena, Govind Desai, Ocular manifestations of common pulmonary diseases: a narrative review , Monaldi Archives for Chest Disease: Vol. 94 No. 1 (2024)
- Cristina Castello, Furio Colivicchi, Mariagrazia Sclavo, Massimo Uguccioni, Alberto Genovesi Ebert, Maurizio G. Abrignani, Pompilio Faggiano, Carmine Riccio, From risk charts to guidelines: tools for evaluation and management of cardiovascular risk , Monaldi Archives for Chest Disease: Vol. 66 No. 1 (2006): Cardiac series
- N. Ambrosino, M. Di Giorgio, A. Di Paco, The patients with severe Chronic Obstructive Pulmonary Disease and chronic respiratory insufficiency , Monaldi Archives for Chest Disease: Vol. 67 No. 3 (2007): Pulmonary series
- Sergio Baldi, Francesco Coni, Giorgio Limerutti, Massimo Baccega, Enrico Ruffini, Paolo Solidoro, Delayed functional improvement after near-fatal bleeding complication following endobronchial valve therapy for emphysema , Monaldi Archives for Chest Disease: Vol. 81 No. 1-2 (2015): Pulmonary series
- P. Santus, L. Bassi, A. Airoldi, F. Giovannelli, D. Radovanovic, Varenicline and evaluated outcomes in smoking cessation programmes , Monaldi Archives for Chest Disease: Vol. 79 No. 1 (2013): Pulmonary series
- Cesare Greco, Rivaroxaban in non valvular atrial fibrillation: subgroups analysis , Monaldi Archives for Chest Disease: Vol. 82 No. 1 (2014): Cardiac series
- Francesca Cesari, Anna Maria Gori, Ilaria Romagnuolo, Rosanna Abbate, Endothelial progenitor cells and vascular health: effects of lifestyle’s modifications , Monaldi Archives for Chest Disease: Vol. 78 No. 2 (2012): Cardiac series
<< < 14 15 16 17 18 19 20 21 22 23 > >>
You may also start an advanced similarity search for this article.